Kun Wang is an Associate Principal Scientist in Translational Medicine at 阿斯利康, focusing on early development and biomarker assay research. Previously, Wang worked as a Translational Medicine Scientist at Bristol Myers Squibb, where responsibilities included biomarker assessment and vendor management. Before that, Wang served as a Biomarker Manager at CSPC Pharmaceutical Group, handling biomarker data analysis and clinical trial duties. Wang completed a Doctorate Degree in Molecular Genetics from Fudan University and conducted postdoctoral research at Huashan Hospital, Fudan University, exploring neuro autoimmune diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices